Original Research
Published on 02 Feb 2021
The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2020.608609
- 7,758 views
- 35 citations
